Robert W. Baker, MD | Psychiatrist.com

Original Research

Clozapine and Risperidone in Moderately Refractory Schizophrenia: A 6-Month Randomized Double-Blind Comparison

May 25, 2016

Nina R. Schooler, Stephen R. Marder, K. N. R. Chengappa, et al

Original Research

Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation

February 9, 2010

Stephen R. Marder, Sebastian Sorsaburu, Eduardo Dunayevich, et al

Original Research

Olanzapine Versus Risperidone in the Treatment of Manic or Mixed States in Bipolar I Disorder: A Randomized, Double-Blind Trial

November 15, 2006

Roy H. Perlis, Robert W. Baker, Eileen B. Brown, et al

Original Research

Risperidone Use at a State Hospital: A Clinical Audit 2 Years After the First Wave of Risperidone Prescriptions

June 30, 1999

K. N. Roy Chengappa, Sapna Sheth, Jaspreet S. Brar, et al

Original Research

Clozapine Withdrawal-Emergent Dystonias and Dyskinesias: A Case Series

September 15, 1998

Shakeel Ahmed, K. N. Roy Chengappa, Venkat Rama Naidu, et al

Letter to the Editor

Gastroesophageal Reflux as a Possible Result of Clozapine Treatment

May 15, 1998

Robert W. Baker, K. N. Roy Chengappa

Letter to the Editor

Possible Dose-Response Relationship for Risperidone in Obsessive-Compulsive Disorder

March 15, 1998

Robert W. Baker

Original Research

Predictive Value of Eosinophilia for Neutropenia During Clozapine Treatment

December 15, 1996

Donna Ames, William C. Wirshing, Robert W. Baker, et al